|1.||Whiteman, David C: 28 articles (11/2015 - 01/2008)|
|2.||Sharma, Prateek: 20 articles (09/2015 - 12/2007)|
|3.||Beer, David G: 19 articles (09/2015 - 07/2003)|
|4.||Meltzer, Stephen J: 19 articles (09/2015 - 06/2005)|
|5.||Siersema, Peter D: 19 articles (08/2015 - 07/2006)|
|6.||Ajani, Jaffer A: 18 articles (10/2015 - 12/2005)|
|7.||Shaheen, Nicholas J: 17 articles (12/2015 - 01/2009)|
|8.||Wang, Kenneth K: 15 articles (09/2015 - 04/2008)|
|9.||Cheng, Yulan: 15 articles (09/2015 - 11/2006)|
|10.||Murray, Liam J: 14 articles (11/2015 - 06/2007)|
05/01/2015 - "We demonstrate the clinical utility of this model by predicting three important clinical outcomes: (1) the probability that small cancers are missed during biopsy-based screening, (2) the potential gains in neoplasia detection probabilities if screening occurred via high-resolution tomographic imaging, and (3) the efficacy of ablative treatments that result in the curative depletion of metaplastic and neoplastic cell populations in BE in terms of the long-term impact on reducing EAC incidence. "
08/01/2008 - "A significant reduction in the incidence of cancer was observed in all groups that received the Viscum album extract compared with the EAC control group. "
09/01/2006 - "In patients with EAC, CCRT improved tumor response significantly compared with traditional CRT alone. "
10/01/2014 - "As HEEPB and AEPB were effective in reducing the severity of morphological and biochemical parameters induced by EAC cells, this study justifies the traditional use of this plant in cancer."
01/01/2013 - "Results of this study conclude that in vivo the A3A was effective in inhibiting the growth of EAC with improving in cancer induced complications."
01/01/2013 - "LTBR with superficial parotidectomy offers the greatest chance of cure for early-stage EAC carcinoma. "
10/01/2005 - "The study suggests, surgical resection followed by postoperative irradiation is an effective method and better treatment option than RT alone as primary treatment modality for carcinoma of EAC."
09/01/1994 - "Study on the cell membrane fluidity of carcinoma cells in EAC mice demonstrates that LWDHT can decrease the cell membrane fluidity, suggesting that it can inhibit division of carcinoma cells."
03/01/2015 - "Twenty patients had carcinoma of EAC, early stage (T1, T2) 36.4% and late stage (T3, T4) 63.6%. "
01/01/2014 - "Our survival analysis data for carcinoma of the EAC demonstrates that SCC and unresectable cases are associated with poor outcomes. "
01/01/2013 - "The newly synthesized complex resulted in inhibition of proliferation of EAC cells and ascites formation. "
05/01/2012 - "The synthesized complexes resulted in inhibition of proliferation of EAC cells and ascites formation. "
01/01/2012 - "EESM caused a significant (p < 0.01) decrease in ascites volume, packed cell volume and viable cell count, and also prolonged the life span of EAC tumour-bearing mice. "
10/01/2007 - "One day after the last injection half of the mice with EAC were sacrificed and antitumor activity was assessed by means of ascites volume inhibition. "
07/01/1991 - "In the presence of ascites fluid in the culture medium, EAC cells progressed through G1 and S phases but accumulated in G2. "
11/15/2007 - "Given the poor survival rate and efficacy of current therapy for esophageal adenocarcinoma (EAC), there is a need to identify and develop new therapeutic targets for treatment. "
07/01/2013 - "The few studies that have previously investigated HPV and esophageal adenocarcinoma (EAC) or BE have produced either negative data or positive results of doubtful clinical/etiological significance or have detected only low-risk HPV types. "
11/01/2008 - "The efficacy of screening and surveillance EGD for esophageal adenocarcinoma (EAC) is controversial. "
02/01/2015 - "In this study we investigated the functional role of CAFs in oesophageal adenocarcinoma (EAC). "
01/01/2015 - "The purpose of this study was to evaluate serum HE4 as a biomarker to detect recurrent disease during follow-up of patients with endometrial adenocarcinoma (EAC). "
07/01/1983 - "The results of this study show a statistically significant reduction in the incidence of secondary hemorrhage in the patients receiving aminocaproic acid."
09/01/1997 - "It is as effective as systemic aminocaproic acid in reducing secondary hemorrhage. "
01/01/2007 - "This study investigates the efficacy of an aminocaproic-acid seal to prevent or reduce the risk of bleeding attendant to liver biopsies. "
11/01/1995 - "The efficacy of aminocaproic acid could not be determined due to the low incidence of hemorrhage. "
01/01/2013 - " aminocaproic acid reduced the rate of recurrent hemorrhage (odds ratio (OR) 0.25, 95% confidence interval (CI) 0.11 to 0.57), but a sensitivity analysis omitting studies not using an intention-to-treat (ITT) analysis reduced the strength of the evidence (OR 0.41, 95% CI 0.16 to 1.09). "
|1.||Tranexamic Acid (AMCA)
|4.||DNA (Deoxyribonucleic Acid)
|5.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|3.||Heterologous Transplantation (Xenotransplantation)